191 related articles for article (PubMed ID: 9687944)
1. [Clinical uses of proton magnetic resonance spectroscopy of the brain].
Laubenberger J; Bayer S; Thiel T; Hennig J; Langer M
Rofo; 1998 Jun; 168(6):539-49. PubMed ID: 9687944
[TBL] [Abstract][Full Text] [Related]
2. MR and 1H MR spectroscopy of the brain in patients with liver cirrhosis and early stages of hepatic encephalopathy.
Tarasów E; Panasiuk A; Siergiejczyk L; Orzechowska-Bobkiewicz A; Lewszuk A; Walecki J; Prokopowicz D
Hepatogastroenterology; 2003; 50(54):2149-53. PubMed ID: 14696484
[TBL] [Abstract][Full Text] [Related]
3. In vivo proton magnetic resonance spectroscopy of the temporal lobe in Alzheimer's disease.
Frederick BD; Lyoo IK; Satlin A; Ahn KH; Kim MJ; Yurgelun-Todd DA; Cohen BM; Renshaw PF
Prog Neuropsychopharmacol Biol Psychiatry; 2004 Dec; 28(8):1313-22. PubMed ID: 15588758
[TBL] [Abstract][Full Text] [Related]
4. Brain lesions in patients with AIDS: H-1 MR spectroscopy.
Chang L; Miller BL; McBride D; Cornford M; Oropilla G; Buchthal S; Chiang F; Aronow H; Beck CK; Ernst T
Radiology; 1995 Nov; 197(2):525-31. PubMed ID: 7480706
[TBL] [Abstract][Full Text] [Related]
5. Absolute quantification in proton magnetic resonance spectroscopy is superior to relative ratio to discriminate Alzheimer's disease from Binswanger's disease.
Watanabe T; Shiino A; Akiguchi I
Dement Geriatr Cogn Disord; 2008; 26(1):89-100. PubMed ID: 18617735
[TBL] [Abstract][Full Text] [Related]
6. Proton magnetic resonance spectroscopy (1H-MRS) findings for the brain in patients with liver cirrhosis reflect the hepatic functional reserve.
Lee JH; Seo DW; Lee YS; Kim ST; Mun CW; Lim TH; Min YI; Suh DJ
Am J Gastroenterol; 1999 Aug; 94(8):2206-13. PubMed ID: 10445551
[TBL] [Abstract][Full Text] [Related]
7. Conversion to dementia in mild cognitive impairment is associated with decline of N-actylaspartate and creatine as revealed by magnetic resonance spectroscopy.
Pilatus U; Lais C; Rochmont Adu M; Kratzsch T; Frölich L; Maurer K; Zanella FE; Lanfermann H; Pantel J
Psychiatry Res; 2009 Jul; 173(1):1-7. PubMed ID: 19427767
[TBL] [Abstract][Full Text] [Related]
8. Metabolic information from the human fetal brain obtained with proton magnetic resonance spectroscopy.
Kok RD; van den Bergh AJ; Heerschap A; Nijland R; van den Berg PP
Am J Obstet Gynecol; 2001 Nov; 185(5):1011-5. PubMed ID: 11717623
[TBL] [Abstract][Full Text] [Related]
9. Cerebral diffusion tensor imaging and in vivo proton magnetic resonance spectroscopy in patients with fulminant hepatic failure.
Saksena S; Rai V; Saraswat VA; Rathore RS; Purwar A; Kumar M; Thomas MA; Gupta RK
J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 2):e111-9. PubMed ID: 17924951
[TBL] [Abstract][Full Text] [Related]
10. In vivo 1H magnetic resonance spectroscopy-derived metabolite variations between acute-on-chronic liver failure and acute liver failure.
Verma A; Saraswat VA; Radha Krishna Y; Nath K; Thomas MA; Gupta RK
Liver Int; 2008 Sep; 28(8):1095-103. PubMed ID: 18266634
[TBL] [Abstract][Full Text] [Related]
11. Magnetic resonance spectroscopy performance for detection of dementia, Alzheimer's disease and mild cognitive impairment in a community-based survey.
García Santos JM; Gavrila D; Antúnez C; Tormo MJ; Salmerón D; Carles R; Jiménez Veiga J; Parrilla G; Torres del Río S; Fortuna L; Navarro C
Dement Geriatr Cogn Disord; 2008; 26(1):15-25. PubMed ID: 18566544
[TBL] [Abstract][Full Text] [Related]
12. Cerebral abnormalities in patients with cirrhosis detected by proton magnetic resonance spectroscopy and magnetic resonance imaging.
Geissler A; Lock G; Fründ R; Held P; Hollerbach S; Andus T; Schölmerich J; Feuerbach S; Holstege A
Hepatology; 1997 Jan; 25(1):48-54. PubMed ID: 8985263
[TBL] [Abstract][Full Text] [Related]
13. Axonal injury and membrane alterations in Alzheimer's disease suggested by in vivo proton magnetic resonance spectroscopic imaging.
Meyerhoff DJ; MacKay S; Constans JM; Norman D; Van Dyke C; Fein G; Weiner MW
Ann Neurol; 1994 Jul; 36(1):40-7. PubMed ID: 8024260
[TBL] [Abstract][Full Text] [Related]
14. Magnetic resonance imaging and localized in vivo proton spectroscopy in patients with fulminant hepatic failure.
Gupta RK; Saraswat VA; Poptani H; Dhiman RK; Kohli A; Gujral RB; Naik SR
Am J Gastroenterol; 1993 May; 88(5):670-4. PubMed ID: 8480729
[TBL] [Abstract][Full Text] [Related]
15. MR spectroscopy and diffusion-weighted MR imaging in focal brain lesions in AIDS.
Chang L; Ernst T
Neuroimaging Clin N Am; 1997 Aug; 7(3):409-26. PubMed ID: 9376961
[TBL] [Abstract][Full Text] [Related]
16. Diffuse white matter disease in three children: an encephalopathy with unique features on magnetic resonance imaging and proton magnetic resonance spectroscopy.
Hanefeld F; Holzbach U; Kruse B; Wilichowski E; Christen HJ; Frahm J
Neuropediatrics; 1993 Oct; 24(5):244-8. PubMed ID: 8309512
[TBL] [Abstract][Full Text] [Related]
17. Localized brain proton MRS metabolic patterns in HIV-related encephalopathies.
Vion-Dury J; Confort-Gouny S; Nicoli F; Dhiver C; Gastaut JA; Gastaut JL; Cozzone PJ
C R Acad Sci III; 1994 Sep; 317(9):833-40. PubMed ID: 7882165
[TBL] [Abstract][Full Text] [Related]
18. A multicenter in vivo proton-MRS study of HIV-associated dementia and its relationship to age.
Chang L; Lee PL; Yiannoutsos CT; Ernst T; Marra CM; Richards T; Kolson D; Schifitto G; Jarvik JG; Miller EN; Lenkinski R; Gonzalez G; Navia BA;
Neuroimage; 2004 Dec; 23(4):1336-47. PubMed ID: 15589098
[TBL] [Abstract][Full Text] [Related]
19. Human fetal brain chemistry as detected by proton magnetic resonance spectroscopy.
Brighina E; Bresolin N; Pardi G; Rango M
Pediatr Neurol; 2009 May; 40(5):327-42. PubMed ID: 19380068
[TBL] [Abstract][Full Text] [Related]
20. Reproducibility of short echo time proton magnetic resonance spectroscopy using point-resolved spatially localized spectroscopy sequence in normal human brains.
Hoshino Y; Yoshikawa K; Inoue Y; Asai S; Nakamura T; Ogino T; Umeda M; Iwamoto A
Radiat Med; 1999; 17(2):115-20. PubMed ID: 10399778
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
